Developments in Hadron therapy, i.e., fast neutrons, protons; pious, heavy
ions and boron neutron capture therapy are reviewed. For each type of parti
cle, operational and closed facilities are listed as well as planned new fa
cilities.
Improvements in clinical results have always been linked to technological d
evelopments and better physical selectivity of the irradiation. Exploring t
he benefit of further improvement in dose localization expected from proton
s and conformal therapy is the challenge for the coming years.
The radiobiological rationale for high-LET radiation in cancer treatment, p
roposed in the fifties, is still valid and has not been contradicted by rec
ent radiobiological findings.
This justifies the planning of a therapy facility where protons and heavy i
ons (carbon ions) could be applied, under optimal physical and technical co
nditions.
Appropriate selection between low- and high-LET radiation for a particular
tumor is indeed a radiobiological problem, independent of technical develop
ment.